Key Events This Very Busy Week: CPI, Retail Sales And Q1 Earnings Start Looking at the busy week ahead, the pandemic will remain in focus as...
Regeneron reported positive data from its Phase 3 trial evaluating REGEN-COV in recently infected asymptomatic COVID-19 patients.
40% Of Marines Refuse COVID-19 Vaccine Just under 40 percent of US Marines are refusing to take the COVID-19 vaccine, according to data obtained by CNN....
Sponsored content brought to you by On February 26, 2021 the world of healthcare had a big reason to celebrate. As the number of reported COVID...
As more people become vaccinated, many of them are eager to resume their social lives. And yet, many are fearful, and some may not want to...
Eli Lilly & Incyte said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized Covid-19 patients
US Colleges Push To Mandate Student Vaccinations Before Fall Semester Authored by Isabel van Brugen via The Epoch Times, A growing number of U.S. colleges are...
Penny Stocks For Your Biotech Watch List
By blocking human enzyme cathepsin L, chemical inhibitor K777 reduces coronavirus’ ability to infect cell lines; clinical trials are underway Credit: National Institute of Allergy and...
In-person learning can safely resume as long as schools take steps to mitigate the spread of COVID-19.
Abbott received U.S. Food and Drug Administration Emergency Use Authorization (EUA) for over-the-counter, non-prescription, asymptomatic use of the company's BinaxNOW COVID-19 Ag Self Test for detection of COVID-19...
List Of Penny Stocks on Robinhood To Watch
Pfizer and BioNTech on March 31 announced data from a Phase III study which showed 100 percent efficacy and robust antibody responses in patients ages 12-15 years...
Big Rock Partners Acquisition Corp (NASDAQ: BRPA) is making an explosive move up the charts after its coming merger partner NeuroRx reported ZYESAMI™ met the primary endpoint for...
Relief Therapeutics Holding AG (OTC: RLFTF) is making a powerful run northbound after NeuroRx reported ZYESAMI™ met the primary endpoint in its Phase 2b/3 trial* for...
Why Are We Vaccinating Children Against COVID-19? Authored by Paul Alexander via The American Institute for Economic Research, The acute focus in this writing is on...
Raw materials shortages causing production delays for Novavax's (NVAX) COVID-19 vaccine forced the company to postpone signing a supply contract with the European Union Thursday.
A readout from a Phase IIb/III trial showed intravenous RLF-100 (aviptadil) met the primary endpoint of improving survival and recovery at 60 days post-treatment for respiratory...
Once a specialist in oncology drugs and pain management, last year, Sorrento Therapeutics (SRNE) refocused its business on addressing the threat from COVID-19. One year later,...
Genetic testing specialist Qiagen received emergency use authorization for a new coronavirus test from the U.S. drugs regulator.
Antibody treatments from Eli Lilly and Vir Biotechnology reduced viral load in low-risk Covid-19 patients, results from a mid-stage trial showed on March 29.
Engineering students in Malawi and Tanzania have used the materials and tools available to them to build ventilators, personal protective equipment and UV disinfection systems.
The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab as a monotherapy just four months after it received FDA emergency use authorization,...
QIAGEN’s NeuMoDx test has received emergency use authorization from the U.S. Food and Drug Administration (FDA). The test helps to quickly identify and differentiate individuals suspected...
Credit: UPMC PITTSBURGH, March 26, 2021 – As evidence mounts supporting the use of monoclonal antibody treatment to reduce hospitalizations and deaths from COVID-19, UPMC and...
The U.S. government has halted distribution of Eli Lilly’s COVID-19 antibody treatment bamlanivimab as a monotherapy just four months after it received FDA emergency use authorization,...
GSK and Vir Biotechnology filed an application to U.S. regulators for emergency use authorization of their antibody therapy to treat early-stage Covid-19 infections, the drugmakers said...
Several U.S. states on March 25 announced broad expansions of their Covid-19 vaccine rollouts, with California opening immunizations to all adults aged 50 and older starting...
In announcing the halt this week, the U.S. Office of the Assistant Secretary for Preparedness and Response (ASPR) said it will continue to distribute bamlanivimab in...
What to make of markets today? Everything is both up and down. The major stock indexes are showing strong gains for the past year, but have...